Press Releases

Deluxe New York Names Barbara Jean Kearney Vice President of Sales

Deluxe has brought on board Barbara Jean Kearney as Vice President of Sales for its New York post production office. Kearney joins Deluxe New York from Technicolor Postworks, where she led feature sales since 2012.

In making the announcement, William Sherak, President of Deluxe Post

June 26th, 2018|Press Center|

RetailMeNot, Inc. Files Patent Infringement Lawsuit Against Honey Science Corp.

AUSTIN, Texas, June 25, 2018 /PRNewswire/ — RetailMeNot, Inc. today announced that it has filed a patent infringement lawsuit against Honey Science Corp. In the complaint, RetailMeNot alleges that Honey has infringed and continues to infringe four of RetailMeNot’s patents, specifically U.S. Patents 9,626,688; 9,639,853; 9,953,335; and

June 25th, 2018|Press Center|

vTv Therapeutics to Present a Poster at the American Diabetes Association’s 78th Scientific Sessions

HIGH POINT, N.C.–(BUSINESS WIRE)–Jun. 22, 2018– vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of new orally administered treatments for Alzheimer’s disease, diabetes and other therapeutic areas, today announced that Company management will present a poster featuring vTv Therapeutics’

June 22nd, 2018|Press Center|

SCANTRON EXPANDS LICENSURE AND CERTIFICATION TESTING WITH ACQUISITION OF CASTLE WORLDWIDE

EAGAN, MN– June 20, 2018 – Scantron Corporation, a global provider of market-leading assessment and technology solutions, today announced it has completed its acquisition of Castle Worldwide, an accomplished full-service licensure and certification testing company based in Morrisville, North Carolina. This acquisition unites unparalleled customer

June 20th, 2018|Press Center|

vTv Therapeutics Announces Topline Results from Part B of Phase 3 STEADFAST Study

HIGH POINT, N.C.–(BUSINESS WIRE)–Jun. 12, 2018– vTv Therapeutics Inc. (Nasdaq:VTVT) today announced that results from Part B of the Company’s STEADFAST Study of the investigational medication azeliragon in people with mild Alzheimer’s disease did not meet co-primary efficacy endpoints. The prespecified subgroup consisted of azeliragon-treated patients

June 12th, 2018|Press Center|

AM General Debuts New Light Tactical Vehicle at Eurosatory 2018

June 11, 2018 | Paris, France – Global vehicle solutions provider AM General continues to innovate and redefine the light tactical vehicle segment with the debut of its next generation light tactical vehicle, the NXT 360. This new product offering highlights evolutionary changes to the already

June 11th, 2018|Press Center|

VALASSIS DIGITAL ENGINEER RECOGNIZED FOR COMPUTER SCIENCE CONTRIBUTIONS

LIVONIA, Mich., June 1, 2018: Valassis Digital, a leading digital marketing intelligence company, announced that Peter Parente, Principal Software Engineer, has been recognized for his contributions on Project Jupyter, as a recipient of the prestigious technical Software System Award from the Association for Computing Machinery (ACM). The award

June 1st, 2018|Press Center|

vTv Therapeutics Announces Licensing Agreement with Newsoara Biopharma Co. Ltd. to Rights for vTv’s PDE4 Inhibitor in China and Other Pacific Rim Territories

HIGH POINT, N.C.–(BUSINESS WIRE)–May 31, 2018– vTv Therapeutics Inc. (Nasdaq:VTVT) today announced that vTv Therapeutics LLC has entered into an exclusive licensing agreement with NewsoaraBiopharma Co., Ltd. for rights to develop and commercialize vTv Therapeutics’ PDE4 Inhibitor program in mainland China, Hong Kong, Macau, Taiwan and other Pacific Rim countries covering Thailand, Vietnam, Indonesia, Malaysia, Philippines, Singapore, Myanmar, Cambodia, Laos, Brunei and South Korea.

Under the terms of the agreement, vTv

May 31st, 2018|Press Center|

SIGA to Present at the Jefferies Global Healthcare Conference on June 8, 2018

NEW YORK, May 31, 2018 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Phillip L. Gomez, SIGA’s Chief Executive Officer, will present at the Jefferies Global Healthcare Conference at 12:30 pm ET on Friday, June 8, 2018 in New York. Dr. Gomez

May 31st, 2018|Press Center|

Revlon Names Debra Perelman President and Chief Executive Officer

NEW YORK–(BUSINESS WIRE)–May 23, 2018– Revlon, Inc. (NYSE:REV) today announced that its Board of Directors has named Chief Operating Officer and Board member Debra G. Perelman President and Chief Executive Officer, effective immediately. Ms. Perelman will be the company’s first female CEO.

This press release

May 23rd, 2018|Press Center|